Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research report sent to investors on Monday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Down 1.0 %

Shares of NYSE RVP opened at $0.80 on Monday. The company has a market capitalization of $23.86 million, a price-to-earnings ratio of -1.48 and a beta of 2.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The business has a 50-day moving average of $0.78 and a two-hundred day moving average of $0.76. Retractable Technologies has a 1 year low of $0.56 and a 1 year high of $1.29.

Institutional Trading of Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC grew its holdings in shares of Retractable Technologies, Inc. (NYSE:RVP) by 9.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 361,253 shares of the company’s stock after buying an additional 31,140 shares during the period. Renaissance Technologies LLC owned 1.21% of Retractable Technologies worth $249,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 7.58% of the stock is owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.